BRUNSWICK CORP (BC) Stock Fundamental Analysis

NYSE:BC • US1170431092

81.16 USD
-2.61 (-3.12%)
Last: Feb 25, 2026, 03:55 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall BC gets a fundamental rating of 4 out of 10. We evaluated BC against 31 industry peers in the Leisure Products industry. While BC is still in line with the averages on profitability rating, there are concerns on its financial health. BC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year BC was profitable.
  • In the past year BC had a positive cash flow from operations.
  • Of the past 5 years BC 4 years were profitable.
  • Each year in the past 5 years BC had a positive operating cash flow.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of BC (-2.58%) is comparable to the rest of the industry.
  • BC has a Return On Equity (-8.45%) which is comparable to the rest of the industry.
  • BC's Return On Invested Capital of 5.91% is fine compared to the rest of the industry. BC outperforms 67.74% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BC is in line with the industry average of 8.11%.
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROIC 5.91%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • BC's Operating Margin of 5.83% is fine compared to the rest of the industry. BC outperforms 70.97% of its industry peers.
  • In the last couple of years the Operating Margin of BC has declined.
  • BC has a worse Gross Margin (24.84%) than 61.29% of its industry peers.
  • BC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.83%
PM (TTM) N/A
GM 24.84%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5Y-2.77%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • BC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BC has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BC has been reduced compared to 5 years ago.
  • BC has a better debt/assets ratio than last year.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • The Debt to FCF ratio of BC is 5.30, which is a neutral value as it means it would take BC, 5.30 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BC (5.30) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.11 is on the high side and indicates that BC has dependencies on debt financing.
  • BC's Debt to Equity ratio of 1.11 is on the low side compared to the rest of the industry. BC is outperformed by 64.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Altman-Z N/A
ROIC/WACC0.67
WACC8.79%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • BC has a Current Ratio of 1.44. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
  • BC has a worse Current ratio (1.44) than 67.74% of its industry peers.
  • BC has a Quick Ratio of 1.44. This is a bad value and indicates that BC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BC's Quick ratio of 0.61 is on the low side compared to the rest of the industry. BC is outperformed by 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.61
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for BC have decreased strongly by -28.29% in the last year.
  • The Earnings Per Share has been decreasing by -8.40% on average over the past years.
  • Looking at the last year, BC shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
  • The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%

3.2 Future

  • BC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.86% yearly.
  • BC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.76% yearly.
EPS Next Y33.12%
EPS Next 2Y27.83%
EPS Next 3Y30.21%
EPS Next 5Y27.86%
Revenue Next Year8.17%
Revenue Next 2Y6.68%
Revenue Next 3Y6.69%
Revenue Next 5Y5.76%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 24.82, which indicates a rather expensive current valuation of BC.
  • Compared to the rest of the industry, the Price/Earnings ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 64.52% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.98, BC is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 18.64, the valuation of BC can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, BC is valued a bit cheaper than 61.29% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.01. BC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.82
Fwd PE 18.64
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 70.97% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BC is valued a bit cheaper than the industry average as 77.42% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 12.06
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BC's earnings are expected to grow with 30.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y27.83%
EPS Next 3Y30.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.04%, BC has a reasonable but not impressive dividend return.
  • BC's Dividend Yield is a higher than the industry average which is at 1.24.
  • Compared to an average S&P500 Dividend Yield of 1.81, BC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

  • On average, the dividend of BC grows each year by 11.57%, which is quite nice.
  • BC has paid a dividend for at least 10 years, which is a reliable track record.
  • BC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.57%
Div Incr Years12
Div Non Decr Years16
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • BC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • BC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-82.01%
EPS Next 2Y27.83%
EPS Next 3Y30.21%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

More info and screens

Find the best dividend stocksShow peers with best dividend

BRUNSWICK CORP

NYSE:BC (2/25/2026, 3:55:02 PM)

81.16

-2.61 (-3.12%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners110.83%
Inst Owner Change-6.73%
Ins Owners0.94%
Ins Owner Change0.11%
Market Cap5.28B
Revenue(TTM)5.36B
Net Income(TTM)-137.30M
Analysts76.43
Price Target89.89 (10.76%)
Short Float %4.3%
Short Ratio3.13
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend1.72
Dividend Growth(5Y)11.57%
DP-82.01%
Div Incr Years12
Div Non Decr Years16
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.15%
Min EPS beat(2)-2.34%
Max EPS beat(2)10.64%
EPS beat(4)3
Avg EPS beat(4)41.04%
Min EPS beat(4)-2.34%
Max EPS beat(4)136.9%
EPS beat(8)4
Avg EPS beat(8)19.7%
EPS beat(12)5
Avg EPS beat(12)11.6%
EPS beat(16)7
Avg EPS beat(16)8.89%
Revenue beat(2)2
Avg Revenue beat(2)5.84%
Min Revenue beat(2)4.71%
Max Revenue beat(2)6.96%
Revenue beat(4)4
Avg Revenue beat(4)7.35%
Min Revenue beat(4)4.71%
Max Revenue beat(4)12.87%
Revenue beat(8)5
Avg Revenue beat(8)2.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-1.2%
PT rev (1m)9.1%
PT rev (3m)19.89%
EPS NQ rev (1m)-38.42%
EPS NQ rev (3m)-39.57%
EPS NY rev (1m)0.77%
EPS NY rev (3m)2.32%
Revenue NQ rev (1m)0.52%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)2.31%
Revenue NY rev (3m)2.69%
Valuation
Industry RankSector Rank
PE 24.82
Fwd PE 18.64
P/S 0.98
P/FCF 13.32
P/OCF 9.39
P/B 3.25
P/tB 58.91
EV/EBITDA 12.06
EPS(TTM)3.27
EY4.03%
EPS(NY)4.35
Fwd EY5.36%
FCF(TTM)6.09
FCFY7.51%
OCF(TTM)8.64
OCFY10.65%
SpS82.45
BVpS24.99
TBVpS1.38
PEG (NY)0.75
PEG (5Y)N/A
Graham Number42.88
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROCE 8.04%
ROIC 5.91%
ROICexc 6.33%
ROICexgc 10.98%
OM 5.83%
PM (TTM) N/A
GM 24.84%
FCFM 7.39%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
ROICexc(3y)9.5%
ROICexc(5y)12.37%
ROICexgc(3y)18.05%
ROICexgc(5y)24.22%
ROCE(3y)11.84%
ROCE(5y)15.22%
ROICexgc growth 3Y-29.65%
ROICexgc growth 5Y-20.68%
ROICexc growth 3Y-27.91%
ROICexc growth 5Y-19.68%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5Y-2.77%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Debt/EBITDA 2.99
Cap/Depr 56.68%
Cap/Sales 3.09%
Interest Coverage 250
Cash Conversion 92.92%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.61
Altman-Z N/A
F-Score5
WACC8.79%
ROIC/WACC0.67
Cap/Depr(3y)73.55%
Cap/Depr(5y)107.72%
Cap/Sales(3y)3.6%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
EPS Next Y33.12%
EPS Next 2Y27.83%
EPS Next 3Y30.21%
EPS Next 5Y27.86%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%
Revenue Next Year8.17%
Revenue Next 2Y6.68%
Revenue Next 3Y6.69%
Revenue Next 5Y5.76%
EBIT growth 1Y-27.9%
EBIT growth 3Y-31.52%
EBIT growth 5Y-10.54%
EBIT Next Year98.59%
EBIT Next 3Y35.47%
EBIT Next 5Y25.45%
FCF growth 1Y50.11%
FCF growth 3Y26.07%
FCF growth 5Y-8.44%
OCF growth 1Y30.3%
OCF growth 3Y-1.38%
OCF growth 5Y-6.78%

BRUNSWICK CORP / BC FAQ

What is the fundamental rating for BC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BC.


What is the valuation status of BRUNSWICK CORP (BC) stock?

ChartMill assigns a valuation rating of 5 / 10 to BRUNSWICK CORP (BC). This can be considered as Fairly Valued.


How profitable is BRUNSWICK CORP (BC) stock?

BRUNSWICK CORP (BC) has a profitability rating of 4 / 10.


What is the valuation of BRUNSWICK CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRUNSWICK CORP (BC) is 24.82 and the Price/Book (PB) ratio is 3.25.


What is the financial health of BRUNSWICK CORP (BC) stock?

The financial health rating of BRUNSWICK CORP (BC) is 3 / 10.